SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 1, 2026

ALKS

Alkermes plc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $368K total
Actionable Insight • Neutral

This cluster is too small to warrant a trade signal. Monitor for any upcoming material filings (earnings, pipeline updates, M&A) that could explain the sales, but the dollar amounts are routine portfolio management. No action needed.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$33.26
T+0 close · Apr 30, 2026 · via day close
Latest settled
+58.55%
T+60 · $52.73
Vs SPY
+55.99%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 1 $33.26entry
  2. T+1 · 7mo ago +2.65%α +2.99% · $34.14
  3. T+5 · 6mo ago +6.44%α +4.10% · $35.40
  4. T+20 · 6mo ago +27.10%α +21.82% · $42.27
  5. T+60 · 4mo ago +58.55%α +55.99% · $52.73
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Alkermes insiders, the EVP/CLO and EVP R&D/Chief Medical Officer, sold a combined $368K in open-market stock over four days, with the CMO also exercising options. The total sales represent ~0.007% of Alkermes' $5.5B market cap, a trivial amount that carries no material signal.

Key Financial Metrics

Direction
selling
Total Value
$368.1K
Insiders
2

Key Facts

  • Two insiders sold a combined $368K in open-market shares over 4 trading days
  • EVP/CLO David Gaffin sold 2,034 shares at $33.20 for $68K on May 4
  • EVP R&D/CMO Craig Hopkinson sold 9,000 shares at $33.40 for $301K on May 1, after exercising options
  • Total sales represent ~0.007% of Alkermes' $5.5B market cap, well below the 0.1% materiality threshold
  • No insider buying was reported in the cluster window

Financial Impact

Total insider sales of $368K, or 0.007% of market cap, economically trivial

Risk Factors

  • Insider selling could accelerate if a negative catalyst emerges, but this cluster alone is not predictive

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (24 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ALKS-1777941791289

Track record

23 reports on ALKS

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.88% at T+60 after the May 12, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $46.98 Now $46.53 −0.96% settles Feb 10
  2. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $44.54 Now $46.53 +4.47% settles Feb 3
  3. Nov 3, 202613d ago 144 Neutral 2/10 Entry $45.89 Now $46.53 +1.39% settles Feb 2
  4. Nov 3, 202613d ago 8-K Neutral 5/10 Entry $45.69 Now $46.53 +1.84% settles Feb 1
  5. Sep 21, 20268w ago 8-K Bullish 6/10 Entry $44.00 Now $46.53 +5.76% settles Dec 15
  6. Sep 16, 20268w ago 8-K Neutral 2/10 Entry $46.07 Now $46.53 +1.00% settles Dec 10
  7. Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $46.10 Now $46.53 +0.93% settles Dec 1
  8. Aug 3, 202615w ago Insider Cluster Bearish 4/10 Entry $49.67 to $44.32 Now $46.53 +6.32% ▲ +10.77% +11.15% vs SPY
  9. Aug 3, 202615w ago Insider Cluster Neutral 2/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
  10. Aug 3, 202615w ago Insider Cluster Neutral 3/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (10h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026